Ritter Pharmaceuticals, Inc. - Special Call Transcript
Good day, and welcome to the Ritter Pharmaceuticals Lactose Intolerance Market Research Conference Call. (Operator Instructions) Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. An archive of the webcast will be available at ritterpharmaceuticals.com approximately 1 hour after the end of the call through November 6, 2019.
This conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that express the current beliefs and expectations of Ritter Pharmaceuticals' management. Any statements contained herein that do not describe historical facts, including statements related to the potential lactose intolerance market opportunity, the anticipated timing for the release data from the Liberatus clinical trial, among other forward-looking statements, are subject to risks and uncertainties that could cause actual results, performance and achievements to differ materially from those discussed in such forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
